Literature DB >> 33991632

Green synthesis of therapeutically active 1,3,4-oxadiazoles as antioxidants, selective COX-2 inhibitors and their in silico studies.

Aravind R Nesaragi1, Ravindra R Kamble2, Shruti Dixit3, Barnabas Kodasi1, Swati R Hoolageri1, Praveen K Bayannavar1, D Jagadish Prasad4, Shyamkumar Vootla3, Shrinivas D Joshi5, Vijay M Kumbar6.   

Abstract

A modest, competent and green synthetic procedure for novel coumarinyl-1,3,4-oxadiazolyl-2-mercaptobenzoxazoles 8i-t has been reported. Analysis of the docked (PDB ID: 5IKR; A-Chain) poses of the compounds illustrated that they adopt identical conformations to the extremely selective COX-2 inhibitor. The biological outcomes as well as computational study suggested that the compounds originated to have elevated resemblance towards COX-2 enzyme than COX-1. The compounds 8i, 8l, 8q, 8r, 8s and 8t emerged as most potent and selective COX-2 inhibitors in contrast with Mefenamic acid. The selectivity index of 8l, 8n and 8r was respectively found to be 33.95, 20.25 and 24.98 which manifested their high selectivity against COX-2. Interestingly, the compounds which were active as COX-2 inhibitors were also active as antioxidant agents.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  1,3,4-oxadiazole; Antioxidant; COX-2 inhibitors; Coumarin; Mercapto benzoxazole; Microwave; Molecular docking

Year:  2021        PMID: 33991632     DOI: 10.1016/j.bmcl.2021.128112

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years.

Authors:  Zhiran Ju; Menglan Li; Junde Xu; Daniel C Howell; Zhiyun Li; Fen-Er Chen
Journal:  Acta Pharm Sin B       Date:  2022-01-11       Impact factor: 14.903

2.  Drug Discovery of New Anti-Inflammatory Compounds by Targeting Cyclooxygenases.

Authors:  Shady Burayk; Kentaro Oh-Hashi; Mahmoud Kandeel
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.